Proteomic analysis identifies proteins associated with curcumin-enhancing efficacy of irinotecan-induced apoptosis of colorectal cancer LOVO cell

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 1, 2014, Pages 1-15

  Zhu, Da Jian ^a   Chen, Xiao Wu ^a   Wang, Jia Zhi ^a   Ju, Yong Le ^a   Yang, Man Zhao Ou ^a   Zhang, Wei Jie ^a  

^a SHUNDE HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Curcumin; Irinotecan; Proteomics

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CURCUMIN; DRUG DERIVATIVE; IRINOTECAN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLORECTAL CANCER; COLORECTAL TUMOR; DRUG EFFECT; HUMAN; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROTEOMICS; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

COLORECTAL CANCER; CURCUMIN; IRINOTECAN; PROTEOMICS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CURCUMIN; HUMANS; PROTEOMICS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84891667908     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Jin P, Wu ZT, Li SR, Li SJ, Wang JH, Wang ZH, Lu JG, Cui XJ, Han Y, Rao J, Sheng JQ. Colorectal cancer screening with fecal occult blood test: A 22-year cohort study. Oncol Lett 2013; 6: 576-582.
2. Wan DS. Epidemiological trend and control strategy of colorectal cancer in China. Zhonghua Zhong Liu Za Zhi 2011; 33: 481-483.
3. Petrelli N, Douglass HO Jr, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Schinella R, Green MD, Muggia FM, et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: A prospective rando-mized phase III trial. Gastrointestinal Tumor Study Group. J Clin Oncol 1989; 7: 1419-1426.
4. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate: Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol 1992; 10: 896-903.
5. O'Connell MJ. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study. Cancer 1989; 63: 1026-1030.
6. Bleiberg H. Role of chemotherapy for advanced colorectal cancer: new opportunities. Semin Oncol 1996; 3: 42-50.
7. Ragnhammar P, Hafstrom L, Nygren P, Glimelius B. Asystematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001; 40: 282-308.
8. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL; Irinotecan Study Group. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000; 343: 905-914.
9. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355: 1041-1047.
10. De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947.
11. Arun B, Frenkel EP. Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues. Expert Opin Pharmacother 2001; 2: 491-505.
12. Lucas AS, O'Neil BH, Goldberg RM. A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer. Clin Colorectal Cancer 2011; 10: 238-244.
13. Schaffer M, Schaffer PM, Zidan J, Bar SG. Curcuma as a functional food in the control of cancer and inflammation. Curr Opin Clin Nutr Metab Care 2011; 14: 588-597.
14. Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011; 16: 4567-4598.
15. Fu S, Kurzrock R. Development of curcumin as an epigenetic agent. Cancer 2010; 116: 4670-4676.
16. Patel BB, Sengupta R, Qazi S, Vachhani H, Yu Y, Rishi AK, Majumdar AP. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int J Cancer 2008; 122: 267-273.
17. Wang JZ, Chen XW, Zhu DJ, Ju YL. The influence of curcumin combined with irinotecan to the growth of colorectal cancer LOVO cells in vitro. Zhonghua Shi Yan Wai Ke Za Zhi 2013; 30: 468-470.
18. Bulleid NJ, Ellgaard L. Multiple ways to make disulfides. Trends Biochem Sci 2011; 36: 485-492.
19. Kakihana T, Nagata K, Sitia R. Peroxides and peroxidases in the endoplasmic reticulum: integrating redox homeostasis and oxidative folding. Antioxid Redox Signal 2012; 16: 763-771.
20. Bindoli A, Fukuto JM, Forman HJ. Thiol chemistry in peroxidase catalysis and redox signaling. Antioxid Redox Signal 2008; 10: 1549-1564.
21. Whalen R, Boyer TD. Human glutathione S-transferases. Semin Liver Dis 1998; 18: 345-358.
22. Sheehan D, Meade G, Foley VM, Dowd CA. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 2001; 15: 1-16.
23. Wang Y, Leung FC. Acquisition of inverted GSTM exons by an intron of primate GSTM5 gene. J Hum Genet 2009; 54: 271-276.
24. Rowe JD, Patskovsky YV, Patskovska LN, Novikova E, Listowsky I. Rationale for reclassification of a distinctive subdivision of mammalian class Mu glutathione S-transferases that are primarily expressed in testis. J Biol Chem 1998; 273: 9593-9601.
25. Ise R, Kito G, Uno Y. Expression profile of early estradiol-responsive genes in cynomolgus macaque liver: implications for drug-metabolizing enzymes. Drug Metab Pharmacokinet 2012; 27: 451-455.
26. Sau A, Pellizzari Tregno F, Valentino F, Federici G, Caccuri AM. Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 2010; 500: 116-122.
27. Tew KD, Townsend DM. Glutathione-s-transferases as determinants of cell survival and death. Antioxid Redox Signal 2012; 17: 1728-1737.
28. Oetari S, Sudibyo M, Commandeur JN, Samhoedi R, Vermeulen NP. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol 1996; 51: 39-45.
29. Zhang B, Wang Y, Su Y. Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett 2009; 286: 154-160.
30. Neumann CA, Fang Q. Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 2007; 7: 375-380.
31. Butterfield LH, Merino A, Golub SH, Shau H. From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid Redox Signal 1999; 1: 385-402.
32. Nyström T, Yang J, Molin M. Peroxiredoxins, gerontogenes linking aging to genome instability and cancer. Genes Dev 2012; 26: 2001-2008.
33. Leydold SM, Seewald M, Stratowa C, Kaserer K, Sommergruber W, Kraut N, Schweifer N. Peroxireduxin-4 is Over-Expressed in Colon Cancer and its Down-Regulation Leads to Apoptosis. Cancer Growth and Metastasis 2011; 4: 7-23.
34. Zhang B, Wang Y, Su Y. Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett 2009; 286: 154-160.
35. Huang Y, Wang KK. The calpain family and human disease. Trends Mol Med 2001; 7: 355-362.
36. Xu L, Deng X. Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains. J Biol Chem 2006; 281: 35567-35575.
37. Pamonsinlapatham P, Gril B, Dufour S, Hadj-Slimane R, Gigoux V, Pethe S, L'hoste S, Camonis J, Garbay C, Raynaud F, Vidal M. Capns1, a new binding partner of RasGAP-SH3 domain in K-Ras(V12) oncogenic cells: modulation of cell survival and migration. Cell Signal 2008; 20: 2119-2126.
38. Asangani IA, Rasheed SA, Leupold JH, Post S, Allgayer H. NRF-1, and AP-1 regulate the promoter of the human calpain small subunit 1(CAPNS1) gene. Gene 2008; 410: 197-206.
39. Hartmann E, Görlich D, Kostka S, Otto A, Kraft R, Knespel S, Bürger E, Rapoport TA, Prehn S. A tetrameric complex of membrane proteins in the endoplasmic reticulum. Eur J Biochem 1993; 214: 375-381.
40. Wang Z, VandeBerg JL. Cloning and molecular characterization of a human ortholog of Monodelphis TRAPD in ultraviolet B-induced melanoma. Melanoma Res 2004; 14: 107-114.
41. Holthuis JC, van Riel MC, Martens GJ. Translocon-associated protein TRAP delta and a novel TRAP-like protein are coordinately expressed with pro-opiomelanocortin in Xenopus intermediate pituitary. Biochem J 1995; 312: 205-213.
42. Brenner V, Nyakatura G, Rosenthal A, Platzer M. Genomic organization of two novel genes on human Xq28: compact head to head arrangement of IDH gamma and TRAP delta is conserved in rat and mouse. Genomics 1997; 44: 8-14.
43. Wilkinson B, Gilbert HF. Protein disulfide isomerase. Biochim Biophys Acta 2004; 1699: 35-44.
44. Xu S, Butkevich AN, Yamada R, Zhou Y, Debnath B, Duncan R, Zandi E, Petasis NA, Neamati N. Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment. Proc Natl Acad Sci U S A 2012; 109: 16348-16353.
45. Xiong Y, Manevich Y, Tew KD, Townsend DM. S-Glutathionylation of Protein Disulfide Isomerase Regulates Estrogen Receptor a Stability and Function. Int J Cell Biol 2012; 2012: 273549.
46. Yoon JS, Kim HM, Yadunandam AK, Kim NH, Jung HA, Choi JS, Kim CY, Kim GD. Neferine isolated from Nelumbo nucifera enhances anti-cancer activities in Hep3B cells: Molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response. Phytomedicine 2013; 20: 1013-1022.